Status:
COMPLETED
Effects of Septorhinoplasty on Allergic Rhinitis
Lead Sponsor:
Mario Pérez Sayáns
Collaborating Sponsors:
Universidade da Coruña
Conditions:
Allergic Rhinitis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Allergic rhinitis (AR) is a chronic inflammatory disease that affects almost 30% of adult population. Some patients associate septal deviation, main cause of chronic nasal obstruction, and AR. Current...
Detailed Description
This is a prospective quasi experimental study. After being informed about the study, patients that signed written informed consent were included in the study. In week 0 before surgery, all measuremen...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Allergic Rhinitis
- Diagnosis of nasal obstruction with septal deviation
Exclusion
- Previous nasal surgery
- Smokers
- Chronic obstructive pulmonary disease
- Psychiatric disorders
- Malignant tumors
- Severe hepatopathy
- Obstructive sleep apnea
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04871256
Start Date
January 1 2021
End Date
March 1 2021
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mario Pérez Sayáns
Santiago de Compostela, A Coruña, Spain, 15785